Page last updated: 2024-12-06
isobutyl chloroformate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Cross-References
ID Source | ID |
---|---|
PubMed CID | 62365 |
SCHEMBL ID | 1745 |
MeSH ID | M0117769 |
Synonyms (70)
Synonym |
---|
chlorocarbonic acid isobutyl ester |
2-methylpropyl carbonochloridate |
2-methylpropyl chloroformate |
isobutyl chloroformate |
chloroformic acid isobutyl ester |
nsc8429 |
543-27-1 |
carbonochloridic acid, 2-methylpropyl ester |
isobutyl chlorocarbonate |
nsc-8429 |
inchi=1/c5h9clo2/c1-4(2)3-8-5(6)7/h4h,3h2,1-2h |
isobutyl chloroformate, 98% |
i-butyl chloroformate |
AKOS000121338 |
A7899 |
isobutyl carbonochloridate |
iso-butylchloroformate |
isobutylchloroformate |
BBL011424 |
unii-6s785tc0ob |
einecs 208-840-1 |
formic acid, chloro-, isobutyl ester |
6s785tc0ob , |
isobutyl chloroformate [na2742] [poison] |
nsc 8429 |
STL146531 |
FT-0627353 |
BP-31022 |
SCHEMBL1745 |
carbonochloridic acid 2-methylpropyl ester |
isobutyl chlorocarbonate [mi] |
i-buococl |
isobutyichioroformate |
chloroformic acid isobutyl-ester |
2-methylpropyl chlorocarbonate |
isobutylchoroformate |
clcooi-bu |
isobutyl choroformate |
iso-butyl chloroformate |
2-methylpropyloxycarbonylchloride |
isobutyl chloroform ate |
chloroformic acid iso-butyl ester |
ibuococl |
clco2ibu |
i-butylchloroformate |
clco2i-bu |
chloroformic acid isobutylester |
ibcf |
isobutyl chloridocarbonate |
iso-butyl-chloroformate |
isobutyl chloroformat |
isobutylchlorocarbonate |
2-methylpropylchloroformate |
chloroformic acid-isobutylester |
isobutyl-chloroformate |
isobutyl chloro-formate |
isobutyloxycarbonyl chloride |
isobutyl chioroformate |
isobutlychloroformate |
2-methylpropoxycarbonyl chloride |
isobutyl chlo-roformate |
isobutylchlorformate |
DTXSID8052194 |
F0001-1428 |
mfcd00000642 |
isobutyl chloroformate, purum, >=98.0% (gc) |
VS-02945 |
Q27265420 |
SB40458 |
EN300-17639 |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" From the calculation of the excretion kinetics it was found that the dosage absorbed was eliminated within 15 h after exposure." | ( Analytical method for biomonitoring of perfluoroalkyl acids in human urine. Ballesteros, E; Gallego, M; Jurado-Sánchez, B, 2014) | 0.4 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (16)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 2 (12.50) | 18.7374 |
1990's | 4 (25.00) | 18.2507 |
2000's | 5 (31.25) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 45.25
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (45.25) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 17 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |